The High Court of Delhi has accepted an application by the Japanese drug maker Daiichi Sankyo to block the sale of the Indian hospital group Fortis Healthcare to the private equity house TPG today. The Singh brothers, who own 83% of the group, were reportedly considering an INR 3,000 crore (US$451m) bid for a 26% stake in the group with a “control premium”.



